4.5 Review

Nuclear Receptors and Liver Disease: Summary of the 2017 Basic Research Symposium

Journal

HEPATOLOGY COMMUNICATIONS
Volume 2, Issue 7, Pages 765-777

Publisher

JOHN WILEY & SONS LTD
DOI: 10.1002/hep4.1203

Keywords

-

Funding

  1. National Institutes of Health [DK104656, ES025909, AA024935, AA026322]
  2. National Cancer Institute [2R01-139158]
  3. VA Merit award [1I01BX002634]
  4. Schaeffer Foundation
  5. Hench Foundation

Ask authors/readers for more resources

The nuclear receptor superfamily contains important transcriptional regulators that play pleiotropic roles in cell differentiation, development, proliferation, and metabolic processes to govern liver physiology and pathology. Many nuclear receptors are ligand-activated transcription factors that regulate the expression of their target genes by modulating transcriptional activities and epigenetic changes. Additionally, the protein complex associated with nuclear receptors consists of a multitude of coregulators, corepressors, and noncoding RNAs. Therefore, acquiring new information on nuclear receptors may provide invaluable insight into novel therapies and shed light on new interventions to reduce the burden and incidence of liver diseases.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available